Loading company details...
Beta
Latest Form 4 (Nov 5, 2024): School Of Medicine At Mount Sinai Icahn (10% Owner): Other (see footnotes) of 13,366,750 shares, $1.55M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2024 | School Of Medicine At Mount Sinai Icahn | Other (see footnotes) | 13,366,750 | $1.55M |
| Jun 13, 2024 | Joel R. Jung, Interim Chief Financial Office | Grant/Award | 60,000 | n/a |
| Apr 26, 2024 | School Of Medicine At Mount Sinai Icahn | Other (see footnotes) | 9,360,374 | $2.34M |
| Nov 22, 2023 | Catherine Coste | Grant/Award | 95,000 | n/a |
| Nov 22, 2023 | Daniel J. Levangie | Grant/Award | 95,000 | n/a |
| Nov 22, 2023 | Chirag R. Parikh | Grant/Award | 95,000 | n/a |
| Nov 22, 2023 | Christopher Mills | Grant/Award | 95,000 | n/a |
| Nov 22, 2023 | Howard Doran Jr., Chief Business Officer | Grant/Award | 300,000 | n/a |
| Jul 11, 2023 | Thomas H. Mclain, President | Grant/Award | 200,000 | n/a |
| Jul 7, 2023 | Michael J. Donovan, Chief Medical Officer | Grant/Award | 85,731 | n/a |